{"id":"W4400213250","doi":"10.4081/cardio.2024.40","title":"Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FR","year":2024,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surgical Specialties (Canada); Health Care Foundation","funders":"Abbott Vascular; St. Jude Medical; Daiichi Sankyo Europe; Servier; Innosuisse - Schweizerische Agentur für Innovationsförderung; Vifor Pharma; Universität Zürich; CytoSorbents Europe; Deutsche Forschungsgemeinschaft; British Heart Foundation; Sanofi; Abiomed; Horizon Therapeutics; Pfizer; Moderna; MicroPort; Impulse Dynamics; Hamilton Health Sciences; Mundipharma Medical Company, Basel; Kiniksa Pharmaceuticals; Cytokinetics; Biosense Webster; Novo Nordisk; HeartWare; ZOLL Medical Corporation; Regeneron Pharmaceuticals; Boston Scientific Corporation; AstraZeneca; Amarin Corporation; Javna Agencija za Raziskovalno Dejavnost RS; Alexion Pharmaceuticals; Thoratec Corporation; Cardinal Health; Edwards Lifesciences; Amgen; Eli Lilly and Company; Bayer Vital; Bristol-Myers Squibb","keywords":"Medicine; Ejection fraction; MitraClip; Internal medicine; Cardiology; Heart failure; Randomized controlled trial; Mitral regurgitation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009158691,0.0001900237,0.001627034,0.0001647995,0.0000160898,0.0000101849,0.00005665926,0.0001336845,0.000007200287],"category_scores_gemma":[0.0002680519,0.0001196242,0.0007115715,0.0005614455,0.0002638979,0.00003793129,0.00002243557,0.0001587456,0.000001976859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004756758,"about_ca_system_score_gemma":0.0001097049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002108694,"about_ca_topic_score_gemma":0.00002261793,"domain_scores_codex":[0.9977469,0.0008929404,0.0006317656,0.0002828859,0.0002560706,0.0001894808],"domain_scores_gemma":[0.9989305,0.0005154872,0.0001281751,0.000227285,0.0001261924,0.00007232288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1039781,0.00009706517,0.8936653,0.0001632676,0.0009519182,0.00003160621,0.00009868557,0.00001650725,0.00001080913,0.00008994543,0.0002419879,0.0006547583],"study_design_scores_gemma":[0.1848531,0.0004977361,0.8123509,0.0001767202,0.001389818,0.00001609002,0.0001131615,0.000160817,0.000005682288,0.0001256207,0.0002278459,0.00008256618],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936486,0.003594972,0.00002589875,0.0003167301,0.0001339494,0.001785723,0.0002905207,0.00001490995,0.0001886309],"genre_scores_gemma":[0.9990402,0.0001804816,0.0001226967,0.0001302323,0.00006670503,0.0001134351,0.000334953,0.00001017125,0.000001081706],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08131443,"threshold_uncertainty_score":0.4878133,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01189000808189308,"score_gpt":0.3060940833949922,"score_spread":0.2942040753130991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}